Bioresorbable Airway Splint Pivotal Clinical Trial — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Bioresorbable Airway Splint Pivotal Clinical Trial — Stella

Home/Tracheobronchomalacia/

View on ClinicalTrials.gov

Recruiting

Back to Tracheobronchomalacia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Michigan, Ann Arbor, Michigan

Key details

Sponsor

University of Michigan

Collaborators

Materialise

Enrollment target

~35 participants

Started

January 2025

Primary completion

September 2029

Age range

1 Week – 3 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.